|Day Low/High||8.19 / 8.61|
|52 Wk Low/High||7.96 / 25.96|
The intermediate-term sentiment indicators don’t show too much giddiness -- yet -- but look at all the market has on its plate this week.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Tracleer ®1 (bosentan) tablets, 62.
Jim Cramer weighs in on U.S. Steel, Insperity, NovoCure, Aqua America, Universal Display, Teva Pharmaceuticals, Marathon Petroleum and more.
Jim Cramer says investing can be fun and rewarding -- if you really understand what you own. But keep your eye on the Fed this week.
Eli Lilly's plan to eliminate pain could have farther reaching positive effects than just migraines.
Shares of drugmaker Teva surge after receiving an upgrade from Oppenheimer, albeit with a reduced 12-month price target.
Be careful backing Buffett right now, his biggest holdings show increasing profit pressure.
When traders are flailing and investors are drowning, examples work best to illustrate what happens before a bottom is reached.
Shares of Warren Buffett's investment vehicle, Berkshire Hathaway, ended the day below $300,000 for the first time since late March.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that data from the Phase IIIb FOCUS study, which evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who previously...
Shares of Teva plummet Tuesday after UBS downgrades the stock to neutral from buy in light of opioid-related litigation.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa ®1 (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.
U.S. stock futures are lower as caution still prevails amid concerns over the fate of trade talks between Washington and Beijing; the French government says it jobs protected needs in order to support the proposed merger of Fiat Chrysler and Renault; Alibaba is considering raising $20 billion through a second listing in Hong Kong, a report says.
Israeli drugmaker says its payment of $85 million to the state is not an admission of wrongdoing; Johnson & Johnson subsidiary Janssen Pharmaceuticals meanwhile also defends company and says its open to a resolution.
Teva Pharmaceuticals USA and related affiliates of Teva Pharmaceutical Industries Ltd.
Gainers trail losers in Warren Buffett's Berkshire portfolio.
NEW YORK, May 13, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE:TEVA).
China's retaliatory tariffs spark biggest selloff on Wall Street since January.
Do not try to pick a bottom on this stock.
Attorneys general from 44 states allege the nation's largest generic drugmakers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs.
Endo Pharmaceutical is downgraded to underweight from neutral at JPMorgan.
U.S. stock futures fall sharply after China vows to stand its ground in the escalating trade war with the United States; oil prices surge after Saudi Arabia alleges two of its tankers were victims of a 'sabotage attack,' Teva and other drugmakers are alleged to have conspired to artificially inflate and manipulate prices for generic drugs.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Delzicol ®1 (mesalamine) delayed-release capsules, 400 mg, in the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Tarceva ®1 (erlotinib) tablets, 100 and 150 mg, in the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced results from new long-term analyses of the efficacy and safety of fremanezumab, being presented at the 71 st Annual Meeting of the American Academy of Neurology (AAN) in...
But is a Teva turnaround still coming after the stock's 70% loss in the past five years?
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended March 31, 2019.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Letairis ®1 (ambrisentan) Tablets, 5 mg and 10 mg, in the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present data at the 71 st Annual Meeting of the American Academy of Neurology (AAN) in Philadelphia from May 4-10, 2019.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.